Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Songzhen Zhengniao Granules
- Development stage
- Unknown
- Lead developer
- Shenzhen Life Biotechnology
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Songzhen Zhengniao Granules is a Class 1.1 innovative Traditional Chinese Medicine (TCM) developed by Shenzhen Life Biotechnology Co., Ltd. for the treatment of migraine. The formulation is designed according to TCM therapeutic principles to dispel wind, resolve phlegm, and activate blood circulation, specifically targeting the "Wind-Phlegm-Stasis" syndrome (风痰瘀阻证) often associated with chronic headaches. It has undergone standardized clinical evaluation in China, including Phase II and Phase III trials (e.g., CTR20212445), where it demonstrated efficacy in reducing the frequency, duration, and intensity of migraine attacks compared to placebo. As a modern Chinese patent medicine, it represents an effort to provide a validated herbal alternative for migraine management through rigorous clinical testing and standardized manufacturing processes.
- Brand names
- Songzhen Zhengniao Granules
- Other names
- 松珍正脑颗粒Songzhen Zhengniao Keli
Beyond the preview
Go deeper on Songzhen Zhengniao Granules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Songzhen Zhengniao Granules.